Diagnosis and treatment of incidental prostate cancer following TUPVP (a report of 15 cases).
- Author:
Xiaojian GU
1
;
Qingyi ZHU
;
Ping ZHANG
;
Yada ZHANG
;
Zijie LU
;
Yan XU
;
Shugang HUANG
Author Information
- Publication Type:Journal Article
- MeSH: Aged; Aged, 80 and over; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prostate-Specific Antigen; blood; Prostatic Hyperplasia; pathology; surgery; Prostatic Neoplasms; pathology; surgery; Transurethral Resection of Prostate
- From: National Journal of Andrology 2004;10(11):849-854
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the diagnosis and treatment of incidental prostate cancer (IPC) following transurethral plasma kinetic vaporization prostatectomy (TUPVP).
METHODSPathological examinations were conducted on 134 benign prostate hyperplasia specimens by means of series microtomy after TUPVP.
RESULTSFifteen cases of IPC were detected from the total number of TUPVP specimens, with a pick-up rate of 11.2%. Dual testicle resection with endocrine therapy was performed in 4 cases of Stage A2 patients, and endocrine therapy alone was conducted in 9 cases of Stage A1 patients. Thirteen patients were followed up for 7 to 15 months and all lived without cancer (PSA 0.15 - 4.0 microg/L).
CONCLUSIONTUPVP and series microtomy may be helpful to the diagnosis of IPC. Patients at Stage A1 need mere endocrine therapy, while those at Stage A2 warrant dual testicle resection.
